Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for PAVmed Inc. (PAVM : NSDQ)
 
 • Company Description   
PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City.

Number of Employees: 39

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.55 Daily Weekly Monthly
20 Day Moving Average: 126,529 shares
Shares Outstanding: 17.09 (millions)
Market Capitalization: $9.47 (millions)
Beta: 1.06
52 Week High: $1.90
52 Week Low: $0.54
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -16.41% -18.92%
12 Week -22.51% -32.83%
Year To Date -11.66% -16.55%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
360 MADISON AVENUE 25TH FLOOR
-
NEW YORK,NY 10017
USA
ph: 917-813-1828
fax: -
mjr@pavmed.com http://www.pavmed.com
 
 • General Corporate Information   
Officers
Lishan Aklog - Chief Executive Officer and Chairman
Michael J. Glennon - Vice Chairman
Dennis M. McGrath - President and Chief Financial Officer
Debra J. White - Director
Ronald M. Sparks - Director

Peer Information
PAVmed Inc. (ABMD)
PAVmed Inc. (DMDS)
PAVmed Inc. (CPWY.)
PAVmed Inc. (EQUR)
PAVmed Inc. (ECIA)
PAVmed Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 70387R403
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/12/25
Share - Related Items
Shares Outstanding: 17.09
Most Recent Split Date: 12.00 (0.07:1)
Beta: 1.06
Market Capitalization: $9.47 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.31 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.07 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/12/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.75
Price/Cash Flow: -
Price / Sales: 4.75
EPS Growth
vs. Year Ago Period: 85.86%
vs. Previous Quarter: -7.69%
Sales Growth
vs. Year Ago Period: -99.21%
vs. Previous Quarter: -20.00%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -42.29
12/31/24 - -66.68
Current Ratio
06/30/25 - -
03/31/25 - 0.37
12/31/24 - 0.06
Quick Ratio
06/30/25 - -
03/31/25 - 0.37
12/31/24 - 0.06
Operating Margin
06/30/25 - -
03/31/25 - -814.05
12/31/24 - -767.38
Net Margin
06/30/25 - -
03/31/25 - 3,711.54
12/31/24 - 1,328.58
Pre-Tax Margin
06/30/25 - -
03/31/25 - 3,289.61
12/31/24 - 949.15
Book Value
06/30/25 - -
03/31/25 - 0.74
12/31/24 - -0.92
Inventory Turnover
06/30/25 - -
03/31/25 - 18.08
12/31/24 - 17.55
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - 4.89
12/31/24 - -
 

Powered by Zacks Investment Research ©